Reaction
Endocrine Ophthalmopathy reporting signals
As of the last recalculation, Endocrine Ophthalmopathy appears in 816 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is METHIMAZOLE (PRR 292.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methimazole | 81 | 292.1 | 295.1 |
| Alemtuzumab | 69 | 99.3 | 99.7 |
| Drs. Clotrimazole | 29 | 66.3 | 66.5 |
| Family Wellness Clotrimazole | 29 | 66.3 | 66.5 |
| Clotrimazole Topical | 29 | 66.3 | 66.5 |
| Clotrimazole | 29 | 62.4 | 62.6 |
| Desloratadine | 25 | 61.3 | 61.4 |
| Ketoconazole | 28 | 42.7 | 42.8 |
| Carboxymethylcellulose Sodium | 14 | 38.6 | 38.7 |
| Prednisolone Acetate | 15 | 37.7 | 37.7 |
| Sodium Chloride Tablet | 85 | 32.8 | 32.8 |
| Sodium Chloride Tablets | 85 | 32.8 | 32.8 |
| Sodium Chloride | 90 | 32.5 | 32.6 |
| Dorzolamide Hydrochloride And Timolol Maleate | 8 | 26.1 | 26.1 |
| Rosuvastatin Calcium | 27 | 25.3 | 25.3 |
| Erythromycin | 18 | 25.0 | 25.0 |
| Brimonidine Tartrate | 16 | 23.3 | 23.4 |
| Lifitegrast | 14 | 22.2 | 22.2 |
| Liothyronine Sodium | 7 | 20.7 | 20.7 |
| Azelastine | 12 | 17.3 | 17.3 |
| Thyroid, Porcine | 7 | 16.9 | 16.9 |
| Cetirizine Hcl | 6 | 16.8 | 16.8 |
| Hydroxyzine Hydrochloride | 8 | 15.7 | 15.7 |
| Hydroxyzine Hydrochloride Oral | 8 | 15.7 | 15.7 |
| Timolol Maleate | 6 | 15.6 | 15.6 |
| Cladribine | 5 | 13.3 | 13.4 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 11.9 | 11.9 |
| Rocuronium Bromide | 5 | 10.9 | 10.9 |
| Cannabidiol | 9 | 9.9 | 9.9 |
| Travoprost | 3 | 8.9 | 8.9 |
| Durvalumab | 6 | 7.6 | 7.6 |
| Rimegepant Sulfate | 3 | 6.1 | 6.1 |
| Ranitidine Hydrochloride | 10 | 4.7 | 4.7 |